United States · 
Who invested in Immunome?
Immunome's investors include Robin Hood Ventures.
2010201120122013201420152016
$435KDebt$847KDebt$145KDebt$445KDebt$735KDebt$468KDebt$200KDebt$12MSeries A
United States · Series A startup
Who invested in Immunome
8 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Immunome and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$15Mraised across 8 rounds since 2009, from 8 sources
$435KDebt$847KDebt$145KDebt$445KDebt$735KDebt$468KDebt$200KDebt$12MSeries A
- Latest round
- Series A, $12MOct 2016
- Step-upi
- 61×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $435K Sept 2009
- Biggest round
- $12M Series A · Oct 2016
- Usual gap between rounds
- 13 months the median of 7
The rounds
- Oct 2016Series A$12M
No investor was named in the report.
Reported by FinSMEsSEC filing: $5.1M sold, first sale Jul 2016
- Feb 2015Debt$200K1 new
From a historical funding recordSEC filing: $893K sold, first sale Sept 2014
- Oct 2014Debt$468K
No investor was named in the report.
From a historical funding recordSEC filing: $468K sold, first sale Sept 2014
- Mar 2014Debt$735K
No investor was named in the report.
From a historical funding recordSEC filing: $735K sold, first sale Feb 2014
- Feb 2013Debt$445K
No investor was named in the report.
Reported by sec.govSEC filing: $445K sold, first sale Feb 2013
- Jan 2012Debt$145K
No investor was named in the report.
Reported by sec.govSEC filing: $145K sold, first sale Jan 2012
- Jun 2011Debt$847K
No investor was named in the report.
Reported by sec.govSEC filing: $847K sold, first sale Apr 2010
- Sept 2009Debt$435K
No investor was named in the report.
From a historical funding recordSEC filing: $435K sold, first sale Sept 2009
Founders and team
From Immunome's own website and the SEC filings it signed: 7 on the team.
- Max RosettChief Financial Officer
- Phil TsaiChief Technical Officer
- Sandra G. StonemanChief Legal Officer and Corporate Secretary
- Corleen J RocheExecutive Officeri
- Dennis H GiesingExecutive Officeri
- Michael J MorinExecutive Officeri
- Purnanand SarmaExecutive Officer, Directori
On the board, as filediJohn J LaMattinaMichael D WidlitzMichael J LefenfeldMichael J RappPhilip J WagenheimRichard J Baron
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Immunome as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Immunome
How much has Immunome raised?
Immunome has raised $15M across 8 rounds since 2009.
When did Immunome last raise?
Immunome's most recent round was a Series A of $12M in Oct 2016.
What was Immunome's biggest round?
Its most recent round, $12M in Oct 2016, is also its largest on record.
Who backed Immunome first?
Immunome's first round on record, in Feb 2015, was backed by Robin Hood Ventures.
What stage is Immunome at?
Immunome's latest named round is a Series A, in Oct 2016.
Where is Immunome based?
Immunome is based in the United States.
Companies like Immunome
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.